UCB - 資産





資産 変化する 日付
Alcon AG USD 31.1B 521M 2026-06
Almirall EUR 2.37B 29.97M 2026-06
Amarin USD 634.08M 9.72M 2026-09
argenx SE USD 10.03B 1.35B 2026-06
AstraZeneca USD 119.92B 4.09B 2026-09
Bayer EUR 113.47B 6.18B 2026-09
Genmab DKK 12.52B 139M 2026-06
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
GRIFOLS EUR 20.28B 191M 2026-09
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Lakefront Biotherapeutics EUR 3.35B 21.24M 2026-06
Lonza CHF 18.97B 164M 2025-12
Merck EUR 53.66B 975M 2026-09
Novartis USD 117.15B 4.88B 2026-09
Orion EUR 2.03B 160.3M 2026-09
Recordati EUR 5.46B 89.21M 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 130.29B 1.23B 2026-09
UCB EUR 18.16B 971M 2025-12
Unibail Rodamco EUR 49.68B 1.23B 2025-12